Actively Recruiting
Observational Study on GEP-and Pulm-NET Treated at FPG
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2024-05-07
650
Participants Needed
1
Research Sites
145 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.
CONDITIONS
Official Title
Observational Study on GEP-and Pulm-NET Treated at FPG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histological diagnosis of gastroenteropancreatic or pulmonary neuroendocrine tumor
- Age 18 years or older
- Radiological evidence of resectable, locally advanced, or metastatic disease
- Signed informed consent
- At least one visit following the first oncology visit
You will not qualify if you...
- Missing clinical data needed to define survival outcomes
- No histological diagnosis
- Did not sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Universitario Agostino Gemelli - IRCCS
Rome, Italy, 00168
Actively Recruiting
Research Team
M
Maria Grazia Maratta, MD
CONTACT
G
Giovanni Schinzari, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here